Arkolith/Insider Trading/CYCC/Form 4

Schwartz Brian

DirectorCyclacel Pharmaceuticals, Inc. (CYCC) · full profile →Form 4 · filed Jun 17, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 15, 2021Grant(A)1K—$04K
Jun 15, 2021Grant(A)2K—$04K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 15, 2021Grant(A)2K—$07K
Jun 15, 2021Grant(A)5K—$07K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-21-082597) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML